Involvement of IL-6, Apart from Its Role in Immunity, in Mediating a Chronic Response during Experimental Arthritis

Feldmann, 1996, Role of cytokines in rheumatoid arthritis, Annu Rev Immunol, 14, 397, 10.1146/annurev.immunol.14.1.397 Kishimoto, 1995, Interleukin-6 family of cytokines and gp130, Blood, 86, 1243, 10.1182/blood.V86.4.1243.bloodjournal8641243 Taga, 1997, Gp130 and the interleukin-6 family of cytokines, Annu Rev Immunol, 15, 797, 10.1146/annurev.immunol.15.1.797 Uson, 1997, Soluble interleukin 6 (IL-6) receptor and IL-6 levels in serum and synovial fluid of patients with different arthropathies, J Rheumatol, 24, 2069 Guerne, 1990, IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro, J Immunol, 144, 499, 10.4049/jimmunol.144.2.499 Guerne, 1989, Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis, J Clin Invest, 83, 585, 10.1172/JCI113921 van Leeuwen, 1995, Clinical significance of interleukin-6 measurement in early rheumatoid arthritis: relation with laboratory and clinical variables and radiological progression in a three year prospective study, Ann Rheum Dis, 54, 674, 10.1136/ard.54.8.674 van Leeuwen, 1995, Interleukin-6 in relation to other proinflammatory cytokines, chemotactic activity and neutrophil activation in rheumatoid synovial fluid, Ann Rheum Dis, 54, 33, 10.1136/ard.54.1.33 De Benedetti, 1991, Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis [see comments], Arthritis Rheum, 34, 1158, 10.1002/art.1780340912 Wendling, 1993, Treatment of severe rheumatoid arthritis by anti-interleukin 6 monoclonal antibody, J Rheumatol, 20, 259 Hirano, 1986, Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin, Nature, 324, 73, 10.1038/324073a0 Tamura, 1993, Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6, Proc Natl Acad Sci USA, 90, 11924, 10.1073/pnas.90.24.11924 Riedy, 1992, Inhibitory role of interleukin-6 in macrophage proliferation, J Leukoc Biol, 52, 125, 10.1002/jlb.52.1.125 Castell, 1990, Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6, Hepatology, 12, 1179, 10.1002/hep.1840120517 Heinrich, 1990, Interleukin-6 and the acute phase response, Biochem J, 265, 621, 10.1042/bj2650621 Gauldie, 1987, Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells, Proc Natl Acad Sci USA, 84, 7251, 10.1073/pnas.84.20.7251 Vink, 1990, Accessory factors involved in murine T cell activation. Distinct roles of interleukin 6, interleukin 1 and tumor necrosis factor, Eur J Immunol, 20, 1, 10.1002/eji.1830200102 Ceuppens, 1988, Human T cell activation with phytohemagglutinin. The function of IL-6 as an accessory signal, J Immunol, 141, 3868, 10.4049/jimmunol.141.11.3868 Tilg, 1994, Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55, Blood, 83, 113, 10.1182/blood.V83.1.113.113 Ito, 1992, Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts, Arthritis Rheum, 35, 1197, 10.1002/art.1780351012 Aderka, 1989, IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice, J Immunol, 143, 3517, 10.4049/jimmunol.143.11.3517 Fattori, 1994, Defective inflammatory response in interleukin 6-deficient mice, J Exp Med, 180, 1243, 10.1084/jem.180.4.1243 Romani, 1996, Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans, J Exp Med, 183, 1345, 10.1084/jem.183.4.1345 Xing, 1998, IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses, J Clin Invest, 101, 311, 10.1172/JCI1368 Anguita, 1998, Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis, J Infect Dis, 178, 1512, 10.1086/314448 van de Loo, 1997, Interleukin-6 reduces cartilage destruction during experimental arthritis. A study in interleukin-6-deficient mice, Am J Pathol, 151, 177 Keystone, 1977, Zymosan-induced arthritis: a model of chronic proliferative arthritis following activation of the alternative pathway of complement, Arthritis Rheum, 20, 1396, 10.1002/art.1780200714 Ohshima, 1998, Interleukin 6 plays a key role in the development of antigen-induced arthritis, Proc Natl Acad Sci USA, 95, 8222, 10.1073/pnas.95.14.8222 Brackertz, 1977, Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice, Arthritis Rheum, 20, 841, 10.1002/art.1780200314 Kopf, 1994, Impaired immune and acute-phase responses in interleukin-6-deficient mice, Nature, 368, 339, 10.1038/368339a0 Van Lent, 1992, Cationic immune complex arthritis in mice—a new model. Synergistic effect of complement and interleukin-1, Am J Pathol, 140, 1451 Van Meurs, 1997, Quantification of mRNA levels in joint capsule and articular cartilage of the murine knee joint by RT-PCR: kinetics of stromelysin and IL-1 mRNA levels during arthritis, Rheumatol Int, 16, 197, 10.1007/BF01330296 Watanabe, 1995, Tumor necrosis factor alpha and interleukin-1 beta but not interferon gamma induce vascular cell adhesion molecule-1 expression on primary cultured murine hepatocytes, Biochem Biophys Res Commun, 209, 335, 10.1006/bbrc.1995.1508 Raisanen-Sokolowski, 1997, Sustained anti-CD4/CD8 treatment blocks inflammatory activation and intimal thickening in mouse heart allografts, Arterioscler Thromb Vasc Biol, 17, 2115, 10.1161/01.ATV.17.10.2115 Joosten, 1997, Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction, Arthritis Rheum, 40, 249, 10.1002/art.1780400209 Modur, 1997, Retrograde inflammatory signaling from neutrophils to endothelial cells by soluble interleukin-6 receptor alpha, J Clin Invest, 100, 2752, 10.1172/JCI119821 Romano, 1997, Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment, Immunity, 6, 315, 10.1016/S1074-7613(00)80334-9 Alonzi, 1998, Interleukin 6 is required for the development of collagen-induced arthritis, J Exp Med, 187, 461, 10.1084/jem.187.4.461 Sasai, 1999, Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice, Arthritis Rheum, 42, 1635, 10.1002/1529-0131(199908)42:8<1635::AID-ANR11>3.0.CO;2-Q Brewer, 1998, Neither interleukin-6 nor signalling via tumour necrosis factor receptor-1 contribute to the adjuvant activity of Alum and Freund's adjuvant, Immunology, 93, 41, 10.1046/j.1365-2567.1998.00399.x Kopf, 1998, Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component, J Exp Med, 188, 1895, 10.1084/jem.188.10.1895 Brackertz, 1977, Studies on antigen-induced arthritis in mice. III. Cell and serum transfer experiments, J Immunol, 118, 1645, 10.4049/jimmunol.118.5.1645 van de Loo, 1993, Modulation of cartilage destruction in murine arthritis with anti-IL-1 antibodies, Agents Actions, 39, C211, 10.1007/BF01972769 Kim, 1999, Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis, J Immunol, 162, 3053, 10.4049/jimmunol.162.5.3053 Takeda, 1998, Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice, J Immunol, 161, 4652, 10.4049/jimmunol.161.9.4652 Fukada, 1996, Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis, Immunity, 5, 449, 10.1016/S1074-7613(00)80501-4 Teague, 1997, IL-6 rescues resting mouse T cells from apoptosis, J Immunol, 158, 5791, 10.4049/jimmunol.158.12.5791 Atreya, 2000, Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn's disease and experimental colitis in vivo [In Process Citation], Nat Med, 6, 583, 10.1038/75068 Plows, 1999, Mice lacking mature T and B lymphocytes develop arthritic lesions after immunization with type II collagen, J Immunol, 162, 1018, 10.4049/jimmunol.162.2.1018 Starr, 1997, A family of cytokine-inducible inhibitors of signalling, Nature, 387, 917, 10.1038/43206 Krebs, 2000, SOCS: physiological suppressors of cytokine signaling, J Cell Sci, 113, 2813, 10.1242/jcs.113.16.2813 Endo, 1997, A new protein containing an SH2 domain that inhibits JAK kinases, Nature, 387, 921, 10.1038/43213 Nicholson, 1999, Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction, EMBO J, 18, 375, 10.1093/emboj/18.2.375 De Sepulveda, 1999, Socs1 binds to multiple signalling proteins and suppresses steel factor-dependent proliferation, EMBO J, 18, 904, 10.1093/emboj/18.4.904 Zhang, 1999, The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation, Proc Natl Acad Sci USA, 96, 2071, 10.1073/pnas.96.5.2071 De Sepulveda, 2000, Suppressor of cytokine signaling-1 inhibits VAV function through protein degradation, J Biol Chem, 275, 14005, 10.1074/jbc.C000106200 Marine, 1999, SOCS3 is essential in the regulation of fetal liver erythropoiesis, Cell, 98, 617, 10.1016/S0092-8674(00)80049-5 Marine, 1999, SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality, Cell, 98, 609, 10.1016/S0092-8674(00)80048-3